Health
COVID-19 vaccine innovation could dramatically speed up worldwide production – EurekAlert
A new modified version of the SARS-CoV-2 spike protein has a 10-fold higher expression rate in cell cultures than an earlier version that forms the basis of vaccine candidates currently in clinical trials from Moderna and Novavax. Vaccine manufacturers could …
IMAGE: This is a 3D atomic scale map, or molecular structure, of Hexapro, a modified version of the SARS-CoV-2 spike protein, described in a paper in the journal Science on July…
view more
Credit: University of Texas at Austin.
Responding to a need to quickly develop billions of doses of lifesaving COVID-19 vaccines, a scientific team at The University of Texas at Austin has successfully redesigned a key protein from the coronavirus, and the modification could enable much faster and more …
